UG
0
Active Trials
0
Total Trials
0
Organizations
0
Events
Uganda
Off-label Medical
Reimbursed Care Access
Classical psychedelics (psilocybin, MDMA, DMT, mescaline, ibogaine, 5‑MeO‑DMT, 2C‑series, ayahuasca) are effectively prohibited for general use in Uganda and have no authorised medical reimbursement outside of approved research. Ketamine is widely used and available in Ugandan health facilities as an essential anaesthetic; esketamine (Spravato) has no record of regulatory approval or routine clinical availability in Uganda.
No clinical trials found for this country yet.